Identification of adipocyte plasma membrane-associated protein as a novel modulator of human cytomegalovirus infection.
Saved in:
| Title: | Identification of adipocyte plasma membrane-associated protein as a novel modulator of human cytomegalovirus infection. |
|---|---|
| Authors: | Ye X; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Texas, United States of America., Gui X; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Texas, United States of America., Freed DC; MRL, Merck & Co., Inc., Kenilworth, NJ, United States of America., Ku Z; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Texas, United States of America., Li L; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Texas, United States of America., Chen Y; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Texas, United States of America., Xiong W; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Texas, United States of America., Fan X; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Texas, United States of America., Su H; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Texas, United States of America.; Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, China., He X; MRL, Merck & Co., Inc., Kenilworth, NJ, United States of America., Rustandi RR; MRL, Merck & Co., Inc., Kenilworth, NJ, United States of America., Loughney JW; MRL, Merck & Co., Inc., Kenilworth, NJ, United States of America., Ma N; Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, China., Espeseth AS; MRL, Merck & Co., Inc., Kenilworth, NJ, United States of America., Liu J; Rutgers Medical School of New Jersey, Newark, NJ, United States of America., Zhu H; Rutgers Medical School of New Jersey, Newark, NJ, United States of America., Wang D; MRL, Merck & Co., Inc., Kenilworth, NJ, United States of America., Zhang N; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Texas, United States of America., Fu TM; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Texas, United States of America.; MRL, Merck & Co., Inc., Kenilworth, NJ, United States of America., An Z; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Texas, United States of America. |
| Source: | PLoS pathogens [PLoS Pathog] 2019 Jul 29; Vol. 15 (7), pp. e1007914. Date of Electronic Publication: 2019 Jul 29 (Print Publication: 2019). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7374 (Electronic) Linking ISSN: 15537366 NLM ISO Abbreviation: PLoS Pathog Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1553-7374 |
|---|---|
| DOI: | 10.1371/journal.ppat.1007914 |
